N-nitrosonintedanib or methyl (Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-1-nitroso-2-oxoindoline-6-carboxylate, is a triple angiokinase inhibitor , is a small molecule, competitive that used for the treatment of idiopathic pulmonary fibrosis, interstitial lung disease. it acts to inhibit platelet-derived growth factor, and fibroblast growth factor receptors.
Additional information on N-nitrosonintedanib
Rivera-Ortega, Pilar, et al. “Nintedanib in the Management of Idiopathic Pulmonary Fibrosis: Clinical Trial Evidence and Real-World Experience.” Therapeutic Advances in Respiratory Disease, vol. 12, Jan. 2018, p. 175346661880061, https://doi.org/10.1177/1753466618800618.
Other products related to nintedanib
|Name of Impurity||Catalogue No.|